The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
5‐HT 2A and α1b‐adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants
Abstract
Addictive properties of drugs of misuse are generally considered to be mediated by an increased release of dopamine (DA) in the ventral striatum. However, recent experiments indicated an implication of alpha1b-adrenergic receptors in behavioural responses to psychostimulants and opiates. We show now that DA release induced in the ventral striatum by morphine (20 mg/kg) is completely blocked by prazosin (1 mg/kg), an alpha1-adrenergic antagonist. However, morphine-induced increases in DA release in the ventral striatum were found to be similar in mice deleted for the alpha1b-adrenergic receptor (alpha1b-AR KO) and in wild-type (WT) mice, suggesting the presence of a compensatory mechanism. This acute morphine-evoked DA release was completely blocked in alpha1b-AR KO mice by SR46349B (1 mg/kg), a 5-HT2A antagonist. SR46349B also completely blocked, in alpha1b-AR KO mice, the locomotor response and the development of behavioural sensitization to morphine (20 mg/kg) and D-amphetamine (2 mg/kg). Accordingly, the concomitant blockade of 5-HT2A and alpha1b-adrenergic receptors in WT mice entirely blocked acute locomotor responses but also the development of behavioural sensitization to morphine, D-amphetamine or cocaine (10 mg/kg). We observed, nevertheless, that inhibitory effects of each antagonist on locomotor responses to morphine or D-amphetamine were more than additive (160%) in naïve WT mice but not in those sensitized to either drug. Because of these latter data and the possible compensation by 5-HT2A receptors for the genetic deletion of alpha1b-adrenergic receptors, we postulate the existence of a functional link between these receptors, which vanishes during the development of behavioural sensitization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDMA also strongly affects 5-HT2A receptors, which are important mediators of behavioral sensitization (47–49).”
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Robinson, T. G., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,108
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Kelly, P. H., Seviour, P. W., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90233-4 · Cited by 1,740
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Addiction, Dopamine, and the Molecular Mechanisms of Memory
Berke, J. D., & Hyman, S. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)81056-9 · Cited by 1,184
Pazos, Á., Cortés, R., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90857-1 · Cited by 824
Sesack, S. R., & Pickel, V. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903200202 · Cited by 820
Binding of antipsychotic drugs to human brain receptors
Richelson, E., & Souder, T. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00911-5 · Cited by 608
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
Ichikawa, J., Ishii, H., Bonaccorso, S., Fowler, W. L., O'Laughlin, I. A., & Meltzer, H. Y. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00154.x · Cited by 495
Noradrenergic neurons: Morphine inhibition of spontaneous activity
Korf, J., Bunney, B. S., & Aghajanian, G. K. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90045-4 · Cited by 432
Aghajanian, G. K., & Marek, G. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01224-x · Cited by 376
α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates
Drouin, C., Darracq, L., Trovero, F., Blanc, G., Glowinski, J., Cotecchia, S., & Tassin, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02873.2002 · Cited by 295
Self-citationDecreased blood pressure response in mice deficient of the α 1b -adrenergic receptor
Cavalli, A., Lattion, A.-L., Hümmler, E., Nenniger-Tosato, M., Pedrazzini, T., Aubert, J.-F., Michel, M. C., Yang, M., Lembo, G., Vecchione, C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11589 · Cited by 289
Self-citationGariano, R. F., & Groves, P. M. (1988) · Brain Research · doi:10.1016/0006-8993(88)90606-3 · Cited by 286
Robinson, T. E., Becker, J. B., & Presty, S. K. (1982) · Brain Research · doi:10.1016/0006-8993(82)90690-4 · Cited by 277
Sorensen, S. M., Kehne, J. H., Fadayel, G. M., Humphreys, T. M., Ketteler, H., Sullivan, C. K., Taylor, V. L., & Schmidt, C. J. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38366-7 · Cited by 258
Darracq, L., Blanc, G., Glowinski, J., & Tassin, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02729.1998 · Cited by 253
Self-citationVezina, P., & Stewart, J. (1989) · Brain Research · doi:10.1016/0006-8993(89)91140-2 · Cited by 240
Marek, G. J., & Aghajanian, G. K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00945-5 · Cited by 221
Ventura, R., Cabib, S., Alcaro, A., Orsini, C., & Puglisi‐Allegra, S. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01879.2003 · Cited by 197
霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位
Jakab, R. L., & Goldman‐Rakic, P. S. (1998) · Cited by 182
Doherty, M. D., & Pickel, V. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02062-x · Cited by 178
Changes in Extracellular Dopamine Induced by Morphine and Cocaine: Crucial Control by D2 Receptors
Rougé‐Pont, F., Usiello, A., Benoit‐Marand, M., Gonon, F., Piazza, P. V., & Borrelli, E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03293.2002 · Cited by 177
Jolas, T., & Aghajanian, G. K. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00103-0 · Cited by 171
Millan, M. J., Brocco, M., Gobert, A., Joly, F., Bervoets, K., Rivet, J., Newman‐Tancredi, A., Audinot, V., & Maurel, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00858.x · Cited by 139
Tao, R., & Auerbach, S. B. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00154-b · Cited by 134
O‘Neill, M. F., Heron-Maxwell, C., & Shaw, G. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00240-8 · Cited by 134
Antagonism of 5-Hydroxytryptamine2A Receptors Attenuates the Behavioral Effects of Cocaine in Rats
McMahon, L. R., & Cunningham, K. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29546-x · Cited by 133
Blanc, G., Trovero, F., Vezina, P., Hervé, D., Godeheu, A. ‐., Glowinski, J., & Tassin, J. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00272.x · Cited by 132
Self-citationSchreiber, R., Brocco, M., & Millan, M. J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90643-2 · Cited by 129
Florin, S. M., Kuczenski, R. T., & Segal, D. S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91570-9 · Cited by 124
Dopamine Receptor Antagonists Fail to Prevent Induction of Cocaine Sensitization
White, F. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00093-6 · Cited by 122
Rinaldi, M. L., Congy, C., Santucci, V., Simiand, J., Gautret, B., Neliat, G., Labeeuw, B., Fur, G. L., Soubrié, P., & Brelière, J. C. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10821-5 · Cited by 116
McMahon, L. R., Filip, M., & Cunningham, K. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07781.2001 · Cited by 114
Drouin, C., Blanc, G., Villégier, A., Glowinski, J., & Tassin, J. (2001) · Synapse · doi:10.1002/syn.10023 · Cited by 112
Self-citationReversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist
Moser, P. C., Moran, P. M., Frank, R. A., & Kehne, J. H. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00090-3 · Cited by 111
Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys.
Spealman, R. D. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12081-8 · Cited by 104
Prazosin: Effect on psychomotor-stimulant cues and locomotor activity in mice
Snoddy, A. M., & Tessel, R. E. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90156-6 · Cited by 99
Long lasting changes in morphine‐induced mesolimbic dopamine release after chronic morphine exposure
Spanagel, R., Almeida, O. F. X., & Shippenberg, T. S. (1993) · Synapse · doi:10.1002/syn.890140307 · Cited by 97
Auclair, A. L., Cotecchia, S., Glowinski, J., & Tassin, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09150.2002 · Cited by 89
Self-citationWoolverton, W. L. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90618-6 · Cited by 87
Serotonin Induces EPSCs Preferentially in Layer V Pyramidal Neurons of the Frontal Cortex in the Rat
Lambe, E. K. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.974 · Cited by 86
Crawford, C. A., Choi, F., Kohutek, J. L., Yoshida, S. T., & McDougall, S. A. (2003) · Synapse · doi:10.1002/syn.10301 · Cited by 83
Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization
Jeziorski, M. C., & White, F. J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00779-7 · Cited by 71
Discriminative Stimulus Properties of Cocaine: Enhancement by Monoamine Reuptake Blockers
Kleven, M. S., & Koek, W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37310-0 · Cited by 67
Receptor subtype and density determine the coupling repertoire of the 5-ht2 receptor subfamily
Lucaites, V. L., Nelson, D. L. G., Wainscott, D. B., & Baez, M. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00423-7 · Cited by 67
Knobelman, D. A., Hen, R., Blendy, J. A., & Lucki, I. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29478-7 · Cited by 63
Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration
Ikemoto, K., Nishimura, A., Okado, N., Mikuni, M., Nishi, K., & Nagatsu, I. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02237-4 · Cited by 56
Auclair, A. L., Blanc, G., Glowinski, J., & Tassin, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02714.x · Cited by 55
Self-citationMulder, A. H., Hogenboom, F., Wardeh, G., & Schoffelmeer, A. N. M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05624.x · Cited by 53
Sorensen, S. M., Humphreys, T. M., Taylor, V. L., & Schmidt, C. J. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11377-3 · Cited by 44
Darracq, L., Drouin, C., Blanc, G., Glowinski, J., & Tassin, J. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00578-9 · Cited by 41
Self-citationVezina, P., Blanc, G., Glowinski, J., & Tassin, J. (1994) · Synapse · doi:10.1002/syn.890160204 · Cited by 41
Self-citationAntagonism of the behavioral effects of cocaine and d-amphetamine by prazosin
Tessel, R. E., & Barrett, J. (1986) · Psychopharmacology · doi:10.1007/bf00174057 · Cited by 36
Cortical α1-adrenergic regulation of acute and sensitized morphine locomotor effects
Drouin, C., Blanc, G., Trovero, F., Glowinski, J., & Tassin, J. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00022 · Cited by 31
Self-citationBerthold, C. W., Gonzales, R. A., & Moerschbaecher, J. M. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90646-w · Cited by 30
Ryan, L. J., Tepper, J. M., Young, S. J., & Groves, P. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)91483-0 · Cited by 22
Cornea-Hébert (1999) · doi:10.1002/(sici)1096-9861(19990628)409:2
Cited by
Sorted by citations
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Alex, K. D., & Pehek, E. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.004 · Cited by 658
Opponency revisited: competition and cooperation between dopamine and serotonin
Boureau, Y.-L., & Dayan, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.151 · Cited by 456
Goodman, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 445
The role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 398
There and Back Again: A Tale of Norepinephrine and Drug Addiction
Weinshenker, D., & Schroeder, J. P. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301263 · Cited by 347
Metadata
- Authors
- Auclair, A., Drouin, C., Cotecchia, S., Glowinski, J., & Tassin, J.
- Affiliations
- Inserm (FR)
- Corresponding author
- Tassin, Jean‐Pol
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 20
- Issue
- 11
- Pages
- 3073-3084
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2007935614
- Semantic Scholar
- 6e7f99f756cb4e158e01c8c27ae8be88a5eaa920
- Cited by
- 163
- References
- 63
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 8 · 2018: 3 · 2017: 5 · 2016: 10 · 2015: 3 · 2014: 11 · 2013: 3 · 2012: 3
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Servier
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- 5-HT2A receptor, alpha1B-adrenergic receptor, dopamine release, ventral striatum, morphine, prazosin, behavioral sensitization, locomotor response, psychostimulants, cocaine, amphetamine, receptor interaction, compensatory mechanisms
- MeSH terms
- Adrenergic alpha-Antagonists, Central Nervous System Stimulants, Anesthetics, Local, Animals, Behavior, Animal, Brain Chemistry, Cocaine, Corpus Striatum, Dextroamphetamine, Dopamine, Drug Administration Schedule, Drug Interactions, Fluorobenzenes, Male, Motor Activity, Narcotics, Phenols, Prazosin, Serotonin Antagonists, Time Factors, Microdialysis, Receptors, Adrenergic, alpha-1, Mice, Knockout, Receptor, Serotonin, 5-HT2A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review